OBJECTIVE: Patients with rheumatoid arthritis (RA) have increased coronary atherosclerosis possibly related to increased prevalence of visceral adiposity, insulin resistance, and metabolic syndrome. Epicardial adipose tissue (EAT), a type of visceral fat, may contribute to cardiometabolic risk. The aim of this study was to measure EAT volume in patients with RA and determine its relationship with cardiometabolic risk markers and coronary artery calcium. METHODS: EAT volume and coronary artery calcium score were measured by noncontrast cardiac computed tomography and compared in RA patients (n = 162) and controls (n = 89). The relationships between EAT volume and markers of cardiometabolic risk in RA were examined with adjustment for age, race, and sex. RESULTS: Among RA patients, EAT volume was positively associated with interleukin-6 (P = 0.03), triglycerides (P = 0.004), hypertension (P = 0.01), homeostatic model of insulin resistance (HOMA) (P < 0.001), smoking history (P = 0.04), and homocysteine level (P = 0.001), and negatively associated with high-density lipoprotein (P = 0.005). With further adjustment for waist circumference (a measure of visceral obesity), EAT volume remained independently associated with triglycerides, HOMA, current smoking, and homocysteine level (all P < 0.05). EAT volume was not associated with corticosteroid use or coronary artery calcium score. Patients with metabolic syndrome had significantly greater EAT volume (P < 0.001) and each increase in metabolic syndrome criteria was associated, on average, with a 20% increase (95% confidence interval 14-26%) in EAT volume (P < 0.001). CONCLUSION: EAT volume is associated with metabolic syndrome and cardiometabolic risk factors, including insulin resistance, triglycerides, current smoking, and homocysteine levels, but not with coronary artery calcium in RA patients.
OBJECTIVE:Patients with rheumatoid arthritis (RA) have increased coronary atherosclerosis possibly related to increased prevalence of visceral adiposity, insulin resistance, and metabolic syndrome. Epicardial adipose tissue (EAT), a type of visceral fat, may contribute to cardiometabolic risk. The aim of this study was to measure EAT volume in patients with RA and determine its relationship with cardiometabolic risk markers and coronary artery calcium. METHODS: EAT volume and coronary artery calcium score were measured by noncontrast cardiac computed tomography and compared in RApatients (n = 162) and controls (n = 89). The relationships between EAT volume and markers of cardiometabolic risk in RA were examined with adjustment for age, race, and sex. RESULTS: Among RApatients, EAT volume was positively associated with interleukin-6 (P = 0.03), triglycerides (P = 0.004), hypertension (P = 0.01), homeostatic model of insulin resistance (HOMA) (P < 0.001), smoking history (P = 0.04), and homocysteine level (P = 0.001), and negatively associated with high-density lipoprotein (P = 0.005). With further adjustment for waist circumference (a measure of visceral obesity), EAT volume remained independently associated with triglycerides, HOMA, current smoking, and homocysteine level (all P < 0.05). EAT volume was not associated with corticosteroid use or coronary artery calcium score. Patients with metabolic syndrome had significantly greater EAT volume (P < 0.001) and each increase in metabolic syndrome criteria was associated, on average, with a 20% increase (95% confidence interval 14-26%) in EAT volume (P < 0.001). CONCLUSION: EAT volume is associated with metabolic syndrome and cardiometabolic risk factors, including insulin resistance, triglycerides, current smoking, and homocysteine levels, but not with coronary artery calcium in RApatients.
Authors: Daniel H Solomon; Elizabeth W Karlson; Eric B Rimm; Carolyn C Cannuscio; Lisa A Mandl; JoAnn E Manson; Meir J Stampfer; Gary C Curhan Journal: Circulation Date: 2003-03-11 Impact factor: 29.690
Authors: Hikmet Yorgun; Uğur Canpolat; Tuncay Hazırolan; Ahmet Hakan Ateş; Hamza Sunman; Muhammet Dural; Levent Şahiner; Ergün Barış Kaya; Kudret Aytemir; Lale Tokgözoğlu; Giray Kabakçı; Ali Oto Journal: Int J Cardiol Date: 2011-09-16 Impact factor: 4.164
Authors: Cecilia P Chung; Annette Oeser; Joseph F Solus; Tebeb Gebretsadik; Ayumi Shintani; Ingrid Avalos; Tuulikki Sokka; Paolo Raggi; Theodore Pincus; C Michael Stein Journal: Arthritis Rheum Date: 2008-07
Authors: Benjamin D Long; Jadranka Stojanovska; Richard K J Brown; Anil K Attili; Eizabeth A Jackson; Vladimir Ognenovski Journal: Acad Radiol Date: 2017-08-26 Impact factor: 3.173
Authors: A Temiz; S Ozcan; F Gökmen; E Gazi; A Barutcu; A Bekler; B Altun; A Akbal; F Güneş; H Şen Journal: Z Rheumatol Date: 2014-12 Impact factor: 1.372
Authors: M Pinheiro; J Mancio; G Conceição; W Ferreira; M Carvalho; A Santos; L Vouga; V Gama Ribeiro; A Leite-Moreira; I Falcão-Pires; N Bettencourt Journal: J Nutr Health Aging Date: 2017 Impact factor: 4.075
Authors: Jadranka Stojanovska; Ella A Kazerooni; Mohamad Sinno; Barry H Gross; Kuanwong Watcharotone; Smita Patel; Jon A Jacobson; Hakan Oral Journal: Eur Radiol Date: 2015-03-13 Impact factor: 5.315
Authors: Michelle J Ormseth; Qiong Wu; Shilin Zhao; Ryan M Allen; Joseph Solus; Quanhu Sheng; Yan Guo; Fei Ye; Marisol Ramirez-Solano; S Louis Bridges; Jeffrey R Curtis; Kasey Vickers; C Michael Stein Journal: Ann Rheum Dis Date: 2020-09-21 Impact factor: 19.103
Authors: Daniel Carranza-Leon; Rany Octaria; Michelle J Ormseth; Annette Oeser; Joseph F Solus; Yahua Zhang; Chimalum R Okafor; Jens Titze; C Michael Stein; Cecilia P Chung Journal: Clin Rheumatol Date: 2017-12-14 Impact factor: 2.980